Hospital-acquired sepsis in burn patients: epidemiology, bacterial profiles, and risk factors in a tertiary burn center in Iran
Main Article Content
Abstract
Sepsis is a significant cause of morbidity and mortality in burn patients due to compromised skin integrity and immune dysfunction. Despite advancements in burn care, hospital-acquired infections continue to be a significant challenge, particularly in low-resource settings. This cross-sectional observational study was conducted over a 12-month period at Mousavi Hospital, a tertiary referral burn center in Zanjan, Iran. All patients admitted with burn injuries who remained hospitalized for more than 72 hours were evaluated for hospital-acquired sepsis. Sepsis was diagnosed based on the combination of clinical signs and relevant laboratory and imaging findings. Demographic, clinical, and microbiological data were collected from medical records. Multivariate logistic regression was used to identify independent risk factors. Among 453 burn patients, 176 (38.8%) developed hospital-acquired sepsis. Sepsis was significantly associated with advanced age (p = 0.007), rural residence (p < 0.001), lower educational level (p = 0.004), higher burn severity (p < 0.001), and prolonged hospitalization (p < 0.001). The most commonly isolated microorganism was Pseudomonas aeruginosa (32.1%), followed by Citrobacter spp. (22.6%) and Staphylococcus aureus (15.1%). Multivariate logistic regression identified burn percentage (OR = 1.184, p = 0.001), length of hospital stay (OR = 1.585, p < 0.001), and lower educational level (OR = 0.501, p = 0.005) as independent predictors of sepsis. Hospital-acquired sepsis remains highly prevalent in burn patients. The key independent predictors were Total Body Surface Area (TBSA), duration of hospitalization, and education level. Regular microbial surveillance, timely diagnosis using burn-specific criteria, and targeted infection control measures are essential to reducing sepsis-related complications in this vulnerable population.
Article Details
Section

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
How to Cite
References
[1] Corcione S, Pensa A, Castiglione A, Lupia T, Bortolaso B, Romeo MR, et al. Epidemiology, prevalence and risk factors for infections in burn patients: results from a regional burn centre's analysis. J Chemother. 2021;33(1):62-66.
DOI: 10.1080/1120009X.2020.1780776 PMID: 32588768
[2] Torres MJM, Peterson JM, Wolf SE. Detection of Infection and Sepsis in Burns. Surg Infect (Larchmt). 2021;22(1):20-27.
DOI: 10.1089/sur.2020.348 PMID: 33021433
[3] Williams FN, Herndon DN, Hawkins HK, Lee JO, Cox RA, Kulp GA, et al. The leading causes of death after burn injury in a single pediatric burn center. Crit Care. 2009;13(6):R183.
DOI: 10.1186/cc8170 PMID: 19919684
[4] Bloemsma GC, Dokter J, Boxma H, Oen IM. Mortality and causes of death in a burn centre. Burns. 2008;34(8):1103-7.
DOI: 10.1016/j.burns.2008.02.010 PMID: 18538932
[5] Alp E, Coruh A, Gunay GK, Yontar Y, Doganay M. Risk factors for nosocomial infection and mortality in burn patients: 10 years of experience at a university hospital. J Burn Care Res. 2012;33(3):379-85. DOI: 10.1097/BCR.0b013e318234966c PMID: 22079911
[6] Strassle PD, Williams FN, Weber DJ, Sickbert-Bennett EE, Lachiewicz AM, Napravnik S, et al. Risk Factors for Healthcare-Associated Infections in Adult Burn Patients. Infect Control Hosp Epidemiol. 2017;38(12):1441-1448. DOI: 10.1017/ice.2017.220 PMID: 29081318
[7] Lachiewicz AM, Hauck CG, Weber DJ, Cairns BA, van Duin D. Bacterial Infections After Burn Injuries: Impact of Multidrug Resistance. Clin Infect Dis. 2017;65(12):2130-2136.
DOI: 10.1093/cid/cix682 PMID: 29194526
[8] Yali G, Jing C, Chunjiang L, Cheng Z, Xiaoqiang L, Yizhi P. Comparison of pathogens and antibiotic resistance of burn patients in the burn ICU or in the common burn ward. Burns. 2014;40(3):402-7. DOI: 10.1016/j.burns.2013.07.010
PMID: 23972824
[9] Shupp JW, Pavlovich AR, Jeng JC, Pezzullo JC, Oetgen WJ, Jaskille AD, et al. Epidemiology of bloodstream infections in burn-injured patients: a review of the national burn repository. J Burn Care Res. 2010;31(4):521-8.
DOI: 10.1097/BCR.0b013e3181e4d5e7 PMID: 20616647
[10] Norbury WB, Herndon DN, Branski LK, Chinkes DL, Jeschke MG. Urinary cortisol and catecholamine excretion after burn injury in children. J Clin Endocrinol Metab. 2008;93(4):1270-5. DOI: 10.1210/jc.2006-2158 PMID: 18211976
[11] Latifi NA, Karimi H. Correlation of occurrence of infection in burn patients. Ann Burns Fire Disasters. 2017;30(3):172-176. PMID: 29849518
[12] Mosier MJ, Pham TN. American Burn Association Practice guidelines for prevention, diagnosis, and treatment of ventilator-associated pneumonia (VAP) in burn patients. J Burn Care Res. 2009;30(6):910-28. DOI: 10.1097/BCR.0b013e3181bfb68f PMID: 19826271
[13] Tan M, Lu Y, Jiang H, Zhang L. The diagnostic accuracy of procalcitonin and C-reactive protein for sepsis: A systematic review and meta-analysis. J Cell Biochem. 2019;120(4):5852-5859. DOI: 10.1002/jcb.27870 PMID: 30417415
[14] Roy S, Mukherjee P, Kundu S, Majumder D, Raychaudhuri V, Choudhury L. Microbial infections in burn patients. Acute Crit Care. 2024;39(2):214-225. DOI: 10.4266/acc.2023.01571
PMID: 38863352
 
							 
						 
            
         
             
            